The $570m plan to help with contraceptives and menopause

The federal government has announced a $573 million women’s health package, including subsidies for menopause treatments and new oral contraceptives. Three menopausal hormone therapies and two contraceptive pills will be available through the Pharmaceutical Benefits Scheme, promising savings for eligible patients. Additional promises include new endometriosis and pelvic pain clinics, increased Medicare payments for birth control implants, and higher rebates for menopause health assessments and long-term contraceptive insertion.

Full Article